trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['trastuzumab deruxtecan', 'rux,(-crux),(-trux)']
join ( , ) at 8am today at #asco23 to hear the interim results of the efficacy &amp; safety of trial testing trastuzumab deruxtecan in patients with #solidtumors: #crukfunded
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK